Improving Global Outcomes in Metastatic Breast Cancer
Globally, more than 2 million new cases of breast cancer are diagnosed each year.1 In developed countries like the U.S., about 10-15 percent of all breast cancer cases are diagnosed at an advanced stage.2 But in lower-to-middle income countries, that number rises steeply to 50 - 80 percent of breast cancer cases.2 Pfizer Oncology, in partnership with Susan G. Komen® and the Global Advanced Breast Cancer Alliance, conducted a global analysis of National Cancer Control Plans (NCCPs), policies and programs - identifying gaps in care and opportunities for collaborative, cross-sector policy development that will support the needs of metastatic breast cancer patients. The review, which included 16 countries, showed:
- There is still a need for improved awareness and education
- None of the NCCPs reflected a need to collect stage of diagnosis or recurrence
- None of the countries with an NCCP actually recommended specific coordinated care actions for advanced breast cancer
- Success depends on collaboration between all stakeholders
Results were published in The Breast Journal and presented in a number of international forums in 2018, including the World Cancer Congress in Malaysia.
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca Cancer J Clin. 2018;68(6):394-424.
- Unger-Saldaña K. Challenges to the early diagnosed and treatment of breast cancer in developing countries. World J Clin Oncol. 2014;5(3):465-77.
Ian Read: Contributions to Improving Human Health
Albert Bourla: Breakthroughs that Change Patients' Lives
Ushering in a New Era of Pfizer R&D Productivity
Advancing Our Leading JAK Science
Overcoming Therapy-Resistant Disease
Tackling Respiratory Syncytial Virus (RSV) Through Breakthrough Science and Technology
Catalyzing Innovations in Global Health
Contributing to the UN Sustainable Development Goals
Supporting Digital Health Start-Ups
Improving the Health of Women and Their Families